Airport shuttle abruptly closes leaving travelers stranded, seeking refunds
Airport shuttle abruptly closes leaving travelers stranded, seeking refunds
A Colorado-based airport shuttle company has shut down and abruptly closed its doors, leaving travelers stranded after announcing an uptick in insurance costs and airport fees among other issues.
"With a heavy heart, we've made the decision to shut down," Eight Black Airport Shuttle, based in Longmont, post on its website June 13.
The municipality in Boulder and Weld counties is about 45 miles northwest of the Denver International Airport.
"Like many transportation companies, we've been hit hard by a perfect storm a significant increase in insurance premiums, rising airport and regulatory fees, and steep capital costs," the company wrote. "In the shared ride model, where affordability matters most, we simply can't raise prices enough to cover those costs while still offering the frequency and schedule that our customers expect."
According to its website, the business acquired Green Ride Boulder and Longmont's shared ride operation in 2022.
The Centennial State's shuttle services are regulated by the Colorado Public Utilities Commission.
How to get an airport shuttle refund
According to its website, the dissolved business was "actively working on a system to manage the refund process."
"It is my full intention to refund every single customer, no matter how long it takes," Simon Chen, the business owner wrote. "I know this situation has been a letdown for you and for the Boulder County community."
To initiate a refund, fill out this form: Voucher Refund Request Form
This is a developing story.
Natalie Neysa Alund is a senior reporter for USA TODAY. Reach her at nalund@usatoday.com and follow her on X @nataliealund.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
14 minutes ago
- CBS News
San Jose Earthquakes owner John Fisher puts team on the market
The owner of the San Jose Earthquakes announced Wednesday that he has begun the process of selling the Major League Soccer club. John Fisher, who also owns baseball's Athletics, acquired the Earthquakes with Lew Wolff in 2007 for a $20 million expansion fee, bringing the team back in 2008 after a two-year hiatus. "The San Jose Earthquakes and PayPal Park have been an important part of our lives for nearly two decades," Fisher said in a statement released by the team. "We are proud of the role the Quakes have played in the growth of soccer throughout Silicon Valley. The Bay Area is a special place, and we're deeply grateful to the fans, players and staff who've been with us on this journey." The Earthquakes have hired the New York-based investment firm Moelis & Co. to lead the sale. The Earthquakes, then known as the San Jose Clash, were a founding member of MLS in 1996. The team won MLS Cup titles in 2001 and 2003. The Quakes also own and operate PayPal Park, an 18,000-seat stadium which is also the home of the National Women's Soccer League team Bay FC. "On behalf of Major League Soccer, I want to thank the Fisher family for their longstanding commitment to the Earthquakes and the San Jose community," MLS Commissioner Don Garber said in a statement. "Under their leadership, the club invested in world-class facilities like PayPal Park, built a highly respected youth academy and helped grow the game in one of the nation's most dynamic markets." The Quakes are the second MLS franchise currently up for sale. The Vancouver Whitecaps are the other.
Yahoo
19 minutes ago
- Yahoo
Partners Group buys UK pet-food business MPM from 3i
Partners Group has agreed to buy UK pet-food business MPM Products from its UK private-equity peer 3i. Established 2002, Manchester-based MPM's portfolio includes cat-focused brands such as Applaws, Reveal and Encore. With offices in the UK, Australia, China and US, MPM sells its products in 49 markets globally, according to the company's official Linkedin account. In a statement, 3i said MPM's sales and EBITDA have more than 'doubled' since its investment in 2020, though specific figures were not disclosed. International sales now account for nearly 80% of MPM's revenues across the US, EMEA, and APAC regions, the private-equity firm said. 3i said the "total gross proceeds" to the buy-out house are estimated at approximately £400m ($538.2m). In a separate statement, Partners Group said the cat-food sector is "benefitting from several thematic tailwinds". People are delaying having babies, leading to increased pet ownership and the "premiumisation" of purchases. Thomas Clark, MD for private-equity goods and products at Partners Group, said: "We have been tracking the pet food market as part of our broader thematic research into the 'humanisation' of pets. We believe there is a significant growth opportunity in the premium cat food segment as this has historically been underserved by incumbent producers that are primarily 'dog focused'." The transaction is subject to customary regulatory approvals and is expected to be completed in the third quarter of the year. Julian Bambridge, MPM's CEO, said: "Feeding is one of the key moments when owners interact with their cats, which reinforces a desire to provide something special at these times. At MPM, our goal is to enrich the lives of pets and owners through visibly better food that uses the highest quality natural ingredients and provides core health benefits. We are excited to continue our strong growth under Partners Group's ownership." "Partners Group buys UK pet-food business MPM from 3i" was originally created and published by Just Food, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Yahoo
19 minutes ago
- Yahoo
Here's Why Exelixis (EXEL) is a Strong Value Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors alike. Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term. Different than growth or momentum investors, value-focused investors are all about finding good stocks at good prices, and discovering which companies are trading under what their true value is before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, and Price/Cash Flow to help pick out the most attractive and discounted stocks. Alameda, CA-based Exelixis, Inc. is an oncology-focused biotechnology company that primarily focuses on the discovery, development and commercialization of new drugs for the treatment of difficult-to-treat cancers. The company is leveraging its investments, expertise and strategic partnerships to target an expanding range of tumor types and indications with its clinically differentiated pipeline of small molecules, antibody-drug conjugates (ADCs) and other biotherapeutics. EXEL is a Zacks Rank #2 (Buy) stock, with a Value Style Score of B and VGM Score of A. Shares are currently trading at a forward P/E of 15.9X for the current fiscal year compared to the Medical - Biomedical and Genetics industry's P/E 19.3X. Additionally, EXEL has a PEG Ratio of 0.8 and a Price/Cash Flow ratio of 21.5X. Value investors should also note EXEL's Price/Sales ratio of 4.9X. A company's earnings performance is important for value investors as well. For fiscal 2025, 10 analysts revised their earnings estimate higher in the last 60 days for EXEL, while the Zacks Consensus Estimate has increased $0.30 to $2.61 per share. EXEL also holds an average earnings surprise of 48.6%. Investors should take the time to consider EXEL for their portfolios due to its solid Zacks Ranks, notable earnings and valuation metrics, and impressive Value and VGM Style Scores. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Exelixis, Inc. (EXEL) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
